Abstract
Acrokeratosis paraneoplastica (Bazex syndrome) is a rare paraneoplastic dermatosis associated with internal malignancies. Clinical presentation is characterized by erythematous or violaceous scaly plaques involving the digits, nose, ears, palms, and soles. Nail changes commonly present concurrently with cutaneous manifestations. In this review, we characterize nail changes associated with acrokeratosis paraneoplastica. A total of 48 cases were analyzed. Nail findings were nonspecific, with the most common being nail plate thickening, onycholysis, subungual hyperkeratosis, longitudinal ridging, discoloration, and nail plate loss. In most patients, nail changes involved the majority of fingernails and toenails and most often appeared prior to the diagnosis of malignancy. The most common associated underlying malignancies were squamous cell carcinomas of the head and neck. A diagnosis of acrokeratosis paraneoplastica should be considered in patients with onychodystrophy involving multiple nails with accompanying atypical psoriasiform dermatoses. Screening for internal malignancies may significantly decrease morbidity and mortality for these patients.
Keywords: Acrokeratosis paraneoplastica, Bazex syndrome, Nails, Malignancy, Onychodystrophy, Squamous cell carcinoma
Introduction
Bazex' acrokeratosis paraneoplastica is a rare dermatological condition characterized by erythematous and hyperkeratotic plaques, involving the nose, ears, palm, and soles. Bazex syndrome is associated with internal malignancies, commonly of the upper aerodigestive tract [1, 2, 3]. Cutaneous manifestations commonly appear prior to cancer diagnosis and typically follow 3 distinct clinical stages. Nail dystrophy often presents during the first stage concurrently with papulosquamous plaques on the distal digits, nose, and ears [1, 4]. Nail findings are common amongst acrokeratosis paraneoplastica patients [1]. Our objectives were to characterize nail changes associated with acrokeratosis paraneoplastica, which may be important clues to the presence of internal malignancies.
Methods
The PubMed database was reviewed for the keywords “Bazex Syndrome and nail,” “Acrokeratosis paraneoplastica and nail,” “Acrokeratosis paraneoplastica,” and “Bazex Syndrome.” The search was limited to articles in the English language published between January 1, 1972, and July 15, 2020. In the initial search, 103 articles were identified and 36 were excluded because they did not pertain to acrokeratosis paraneoplastica, leaving 67. Of the 67 remaining articles, 19 did not report any nail changes, leaving a total of 48 articles for final analysis. Cases were analyzed for age, gender, Fitzpatrick skin type, race, primary cancer type, cancer staging, presence of metastasis, cancer treatment, nails involved, nail clinical presentation, and cutaneous findings. Fitzpatrick skin type was determined by examining photos in the articles and using the Fitzpatrick classification guidelines [5]. If photos or descriptions of the patient's skin type were unavailable or photos were black and white, they were recorded as not specified.
Results
There were 48 cases of acrokeratosis paraneoplastica with nail changes included in the final analysis. Demographics and case findings are shown in Table 1. Of these patients, 25% were female, with a mean age of 62.5 years (range 41–84 years). Fifteen patients (31%) were classified as Fitzpatrick skin type I–II, 13 patients (27%) as type III–IV, eleven (23%) patients as type V–VI, and 9 patients (19%) not specified. Eleven patients (23%) were described as either Caucasian or White, 4 patients (8%) African American or Black, 7 patients (14%) Japanese, Korean, or Indian, and the races of 26 patients (55%) were not specified.
Table 1.
Demographics, malignancy, treatment, nail changes, and cutaneous manifestations of patients with Bazex syndrome [1, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 30, 31, 32, 33, 34, 35, 36, 37, 38, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52]
| Author | Age, years | Sex | Skin type | Race | Cancer type | Stage | Metastasis | Treatment | Nails involved | Nail changes | Timing of nail changes in relation to cancer | Cutaneous manifestations |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jacobsen et al. [11] |
63 | M | Not specified | Not specified | Epidermoid carcinoma of lung | Not specified | Liver metastases | None, patient died of bronchopneumonia | All finger and toenails | Tender nail folds. Fingernails: hypertrophic, onycholytic, crumbling, and partially destroyed. Toenails: yellow, hypertrophic, onycholysis | 6 months prior | Pityriasiform scaling of tip of nose, ear helices, toes and distal fingers. Violaceous keratoderma of fingers, palms, toes, and soles |
| Richard et al. [12] | 55 | M | Not specified | White | SCC of esophagus | Not specified | Cervical metastases | Radiotherapy | Majority of fingernails and toenails | Thickened and friable | 4 months prior | Erythema with violaceous hue of nose, lips, cheeks, chin, ears, elbows, and knees. Palmoplantar regions with hyperkeratosis |
| Bolognia et al. [1] |
52 | M | VI | Black | Metastatic SCC of esophagus | Not specified | R upper lobe nodules and R hilar adenopathy, dermal metastasis SCC | Radiation therapy and cisplatin | All finger and toenails | Thickened, yellow/brown discoloration subungual hyperkeratosis and horizontal and longitudinal ridging | 9–10 months prior | Scaling of toes, fingers, and soles. Hyperpigmentation of nose and ears |
| Douglas et al. [13] | 82 | M | Not specified | Not specified | Adenocarcinoma of esophagus | Not specified | Mediastinal lymphadenopathy | Palliative radiotherapy | Majority of fingernails and toenails | Longitudinal ridging and distal thickening of nail plates | 24 months prior | Bluish erythema and scaling of skin over fingers, toes, thenar, and hypothenar eminences. Keratotic lesions on nose and ears |
| Handfield-Jones et al. [14] | 73 | F | II | Caucasian | Poorly differentiated SCC |
Not specified | Intrapulmonary metastasis | Radiotherapy | All fingernails and toenails | Ridging splitting clubbing | 2 months prior | Purple discoloration of fingers and toes with tissue swelling and psoriasiform scaling |
| Handfield-Jones et al. [14] | 65 | M | II | Caucasian | Anaplastic carcinoma of indeterminate origin | Not specified | Cervical lymphadenopathy | Radiotherapy | Toenails only | Loose with sterile paronychia. Subungual and periungual hyperkeratosis | 2 months prior | Surrounding skin swollen and purple |
| Handfield-Jones et al. [14] | 73 | M | II | Caucasian | SCC of R main bronchus | Not specified | Not specified | Not specified | All finger and toenails | Severe flaking and cracking of nails and warty thickening and fissuring of the nail folds | 2 months prior | Dry scaly skin around nails. Thickened and scaling on soles of feet. Purple discoloration of arms and knees. Thickening of skin of axillae |
| Mounsey et al. [15] | 66 | M | II | White | SCC of the glottis | T-3, N-0, M-0 | No | Total laryngectomy, L anterior neck dissection, L hemithyroidectomy | Majority of fingernails and toenails | Longitudinal ridging and nail plate destruction | Not specified | Palmar and plantar hyperkeratosis and superficial pitting |
| Poskitt et al. [16] | 70 | M | III | Not specified | SCC of esophagus | Not specified | Metastasis to tonsil | Excised, digoxin, Navidrex® and Oruvail SR | All fingernails and toenails | Longitudinal ridging | 5 years post | Erythematous scaling of nose and ears, swollen and cyanotic fingers with scaling, erosion and crusting of cuticles |
| Arregui et al. [17] | 41 | M | II | White | SCC of esophagus | Not specified | Lymphadenopathy in the mediastinum and bilateral pulmonary metastases | Palliative treatment with radiotherapy | All fingernails and toenails | Severe onychodystrophy, unspecified | 11 months prior | Erythematosquamous eruption in periungual area of fingers and toes. Fine scales at tips of nose and external ears |
| Arregui et al. [17] | 73 | M | II | White | Recurrence of transitional cell carcinoma of the bladder | Not specified | Not specified | Treatment of local bladder recurrences with of mitomycin C | All fingernails and toenails | Distal shedding and yellowish discoloration | Few weeks prior | Erythematosquamous, psoriasiform eruption of periungual skin. Moderate plantar hyperkeratosis and desquamative cheilitis |
| O'Brien et al. [9] |
67 | F | V | Not specified | Oropharyngeal carcinoma | Not specified | Not specified | 5-fluorouracil and carboplatinum | Not specified | Loss of the nail plate | Simultaneously with recurrence | Psoriasiform eruption on fingers and toes extending onto dorsum of hands and feet |
| Hara et al. [18] | 54 | M | III | Japanese | Cutaneous SCC of the lower leg | Not specified | Not specified | Cutaneous SCC excision | All fingernails and toenails | Distal onycholysis. Subungual hyperkeratosis and paronychial erythema | 3 months prior | Scaling, erythematous plaques on nose, ears, trunk and proximal limbs. Erythematous, thick hyperkeratosis with deep fissures of thenar areas, soles, and palms. Vitiligo and alopecia areata of the scalp |
| Laccourreye et al. [19] | 62 | M | Not specified | Not specified | Well-differentiated SCC of pyriform sinus | Not specified | Distant metastasis | Unresectable. Palliative radiotherapy |
Not specified | Paronychia and thickening of partly destroyed onycholytic nail | 6 months prior | Violaceous psoriasiform erythema and scaling of fingers. Swelling of fingers with periungual acrokeratosis |
| Wareinget al. [20] | 71 | M | II | Caucasian | SCC of unknown primary origin | Not specified | Enlarged mediastinal nodes | Radiotherapy | All fìnger and toenails | Ridges and ragged cuticles | 18 months prior | Psoriasiform scaling of fingers, lower shins and buttocks. Hyperpigmentation over bridge of the nose |
| Sarkar et al. [21] | 61 | M | III | White | SCC of the L pyriform sinus | T-3, N-0, M-0 | No | Total laryngectomy, partial pharyngectomy and left radical neck dissection | All fingernails and toenails | Yellowish discoloration and periungual swelling | 5 years prior | Acral hyperkeratotic skin lesions and squamous skin lesions at elbows, hands and feet. Painful fissures and scales on heels |
| Mutasim et al. [22] |
67 | M | VI | Black | Moderately differentiated SCC of larynx and vocal cords | Not specified | Not specified | Total laryngectomy, R radical neck dissection, and L modified radical neck dissection | Majority of fingernails and toenails | Loss of the cuticles, swelling of the nail folds, subungual hyperkeratosis, transverse and longitudinal ridging with nail loss | Few weeks prior | Hemorrhagic vesicles of dorsal fingers, hands, feet, ankles, and knees. Erythematous/scaly/fissured papules and plaques on palmar hands fingers, toes. Dusky erythema of the nose and ears |
| Hsu et al. [23] | 63 | M | IV | Not specified | Adenocarcinoma of colon | Stage B1 | No | Low anterior resection | All toenails only | Dystrophic toenails and subungual hyperkeratosis | 1 month prior | Pruritic lesions and vesicles on both feet. Dense scale of palms and soles, with fissures on feet. Similar skin lesions on both ears |
| Buxtorf et al. [24] |
58 | M | Not specified | Not specified | Low-differentiated SCC of the tongue | T-2, N-1, M-0 | No | Chemotherapy and radiotherapy | All fingernails and toenails | Subungual hyperkeratosis and onycholysis | 4 months prior | Scaly erythematous, violaceous plaques on ears and tip of nose with hyperkeratosis of toes and fingers |
| Gill et al. [25] | 59 | M | Not specified | Not specified | SCC of R Pyriform fossa | Not specified | Not specified | Not specified | Majority of fingernails and toenails | Nail dystrophy, thickened, and friable | 4 months prior | Tense bullae on lateral feet with erythematous hyperkeratotic skin. Violaceous plaques of dorsum nose, outer helices and R lateral lower leg |
| Chave et al. [26] | 65 | M | V | Indian | Well-differentiated thymic carcinoma | Stage III | Lung parenchyma and pleural metastases |
Surgically debulked and radiation therapy | All toenails | Thickened and dystrophic | 2 months prior | Violaceous hyperkeratotic plaques on trunk and limbs |
| Rao et al. [27] | 62 | M | V | Indian | Adenocarcinoma of rectosigmoid junction | Not specified |
Not specified | Not specified | A few nails of the hands and feet | Thickening and brownish discoloration of nail plates with subungual hyperkeratosis | 24 months prior | Hyperpigmented scaly papules and plaques over dorsum and palmoplantar surfaces of hands and feet |
| Valdivielso et al. [28] | 64 | M | III | Not specified | SCC of the lung | Stage IIIA (T-2, N-2, M-0) | No | Chemotherapy with carboplatin and paclitaxel | All fingernails and toenails | Longitudinal streaks, subungual hyperkeratosis, and onychomadesis | 2 months prior | Symmetrical red violaceous plaques on dorsum of fingers, hands and feet. Thickening of phalanges and hyperkeratotic plaques on palms and soles. Hyperpigmented plaques and scaly on nasal dorsum and both ears |
| Viteri et al. [29] |
51 | M | II | Not specified | Metastatic SCC of esophagus | Not specified |
Metastatic | Early death of pt | Not specified | Nail detachment with subungual hyperkeratosis | Simultaneously | Hyperkeratotic symmetrical lesions on palms, soles, groin, and scalp |
| Karabulut et al. [30] | 57 | F | Not specified | Not specified | Adenocarcinoma of the choledoch | Not specified |
Not specified | Refused further medical/surgical therapy | Not specified | Subungual hyperkeratosis and longitudinal ridging | 2 months prior | Dusky red psoriasiform plaques, with fine scales on scalp, eyebrows, nasal radix, cheeks, aural helices and gluteal areas; moderate hyperkeratosis on palms and soles |
| Sator et al. [31] | 71 | M | II | Not specified | Liposarcoma in the R retroperitoneum |
Not specified |
Not specified | Two tumor extirpations and radiation therapy | All fingernails | Yellowish discoloration and were slightly thickened | 4 months post | Erythematosquamous plaques on knuckles, fingernails, fingertips, palms, ears, elbows, and neck and diffuse reddening with telangiectasias in face and upper chest |
| Strobel et al. [32] |
58 | M | Not specified | Not specified | SCC of L upper lobe of lung | Not specified |
Cervical lymph node metastasis | Radical neck dissection and radiotherapy. Partial lung resection and radical hilar and mediastinal lymphadenectomy | Not specified | Subungual hyperkeratosis with onycholysis | Not specified | Psoriasiform dermatitis of the nose, helix of the ears, fingers and toes |
| Poligone et al. [33] | 62 | M | VI | Black | SCC of the esophagus | Stage III | No lymphadenopathy | Localized radiation therapy with adjuvant 5-fluorouracil and cisplatin |
Not specified | Thickening with ridging | 2 months prior | Hyperpigmented, erythematous plaques with scales on ears and dorsal surfaces of metacarpophalangeal, proximal interphalangeal, and distal interphalangeal joints of hands and feet. |
| Taher et al. [10] | 68 | F | II | Caucasian | Invasive lobular carcinoma of the L breast | Not specified | Metastatic infiltration of the lungs, bones (cervical spine, femur, pelvis), and mediastinal lymph nodes | Mastectomy and radiation. Docetaxel epoetin alpha | Majority of fingernails and toenails | Fissuring, onycholysis, and nail dystrophy | Simultaneously with recurrence | Hyperkeratotic plaques and ulceration on dorsum of hands. Fissured, scaly plaques and papules on periorbital skin, nose, forehead, chin, and ears |
| Baek et al. [34] | 63 | F | III | Korean | Adenocarcinoma of colon | T-3, N-1, M-0 | No | L hemicolectomy | Majority of fingernails and toenails | Onycholysis | 1 month prior | Yellowish punctuate hyperkeratotic lesions on palms and soles |
| Medinica et al. [35] |
50 | M | IV | White | SCC of the esophagus | Not specified | No | Esophageal resection, subtotal esophagectomy | All fingernails | Yellowish, dystrophic, with subungual hyperkeratosis | 3 months prior | Violaceous erythema, edema, and yellow crusts on nose, chin and auricles. Erythematous plaques on elbows and knees. Palmar and plantar regions with diffuse yellow hyperkeratosis and fissures |
| Crucitti et al. [36] |
55 | M | I | White | Adenocarcinoma of lung | T-2, N-0,M-0 |
No | Upper R lobectomy | All fingernails and toenails | Yellowish discoloration with onychodystrophy | 3.5 years prior | Erythematous hyperkeratotic lesions of the periungual region |
| Ljubenovic et al. [37] | 56 | M | Not specified | Not specified | Anaplastic metastatic carcinoma, unspecified. Pt died before primary tumor found | Not specified | Yes | Patient died | Some finger and toenails | Moderate dystrophic changes, unspecified | 1 month prior | Hyperkeratotic skin changes on his palms, fingers, soles, tip of nose and on earlobes |
| Santos-Silva et al. [38] | 61 | M | II | Caucasian | SCC on lateral border of the tongue | T-2, N-0, M-0 | No | L Hemiglossectomy and supraomohyoid neck dissection. Post-operative radiotherapy | All fingernails and toenails | Vertical ridging widespread thickening, onycholysis | 2 months post | Ulcerations involving lips, buccal mucosa and tongue. Scales on dorsal surfaces of metacarpophalangeal and interphalangeal joints of hand. Mucosa of the glans penis exhibit diffuse red patches |
| Goto et al. [39] | 75 | M | IV | Japanese | Hepatocellular carcinoma (HCC) |
Not specified | Not specified | Partial resection of segment VIII of the liver | All fingernails and toenails | Dystrophic, unspecified | 1 month prior | Thick hyperkeratosis of palms and soles, and scaly erythematous lesions on face and earlobes. Solid reddish papules on the trunk |
| Zarzour et al. [40] | 58 | F | VI | African American | Small cell lung carcinoma | Not specified | Lesion in the liver consistent with metastatic disease | Palliative chemotherapy | Majority of fingernails and toenails | Brittle and atrophied | 24 months prior | Hyperkeratotic plaques on hands and joints. Hyperpigmented macules over dorsal arms and lower legs. Hyperpigmented, scaly patch on nose |
| Rodrigues júnior et al. [41] | 73 | F | V | Not specified | SCC of the esophagus | Not specified | Hepatic nodules and lymphadenomegaly | None, patient died | All fingernails and toenails | Yellow hyperchromia and onychomadesis | 2.5 months prior | Violet, desquamative lesions on nose, auricular pavilions, dorsal hands, feet, and toes. Symmetric palmoplantar keratoderma, with lamellar desquamation |
| Fleming et al. [42] | 70 | F | I | Not specified | Metastatic undifferentiated (SCC), primary lesion not identified | Not specified | Liver metastases and cervical lymphadenoparhy | Modified neck dissection and radiotherapy | 9 fingernails and 1 toenail - spread to all nails | Initial presentation − candidal onychomycosis; 4 months later: onycholysis, hyperkeratotic subungal debris, and loss of cuticles in all nails | 24 months prior | Painful, swollen, and erythematous, with scale on dorsal surface. Fine scale in the conchal bowls, antihelix and left ear lobule |
| Graves et al. [43] | 60 | M | VI | Not specified | Basaloid SCC of supraglottic region | Not specified | Diffuse metastases to the bones and viscera | Palliative radiotherapy | All fingernails | Onychomadesis, nail tenderness | 3 weeks prior | Hyperkeratotic, erythematous and hyperpigmented papules/plaques on chest, back, bilateral palms and arms. Erythematous plaques on the glans penis |
| Robert et al. [44] |
73 | F | IV | Not specified | Gastric adenocarcinoma | Not specified | Ovarian metastases | FOLFOX4 chemotherapy | Mainly L fingernails, and R fingernails and toenails | Nail lesions, unspecified | 2 months prior | Skin lesions, unspecified |
| Amano et al. [45] | 82 | M | III | Japanese | R lung (SCC), hx of tongue, and gastric cancer | Not specified | Not specified | Lung lobectomy | All finger and toenails | Nails were thickened and fissures | 6 months prior | Hyperkeratotic erythematous plaques on bilateral palms and soles |
| Squires et al. [46] |
56 | F | VI | Not specified | Cervical SCC | FIGO stage IIB | Not specified | Pelvic external beam radiotherapy, brachytherapy, and chemotherapy | R Fifth fingernail | Irregular pitting | 2 months prior | Scaly hyperpigmented plaques on bilat hands and periungual skin of fingers, with fissuring. Bilat plantar feet demonstrated hyperkeratosis. Xerotic scaling and excoriations on bilateral upper arms, lower legs, and lower back |
| Vatandoust et al. [47] | 69 | M | II | Not specified | Metastatic cutaneous SCC of L forearm | Not specified | L axillary area | Excision, cisplatin and 5-fluorouracil | Not specified | Nail changes present not specified | 18 months prior | Hyperkeratosis and desquamation |
| Zhao et al. [48] | 83 | M | III | Not specified | Pulmonary adenocarcinoma of R lower lobe with local metastatic nodules | Not specified | Diffuse bone metastases. Mediastinal swollen lymph nodes | Gefitinib tablet 250 mg | All fingernails | Yellow-brown and thickened, with subungual keratotic debris | 60 months prior | Infiltrative erythematous plaques with scales on nose, cheeks, ears, and dorsa of interphalangeal joints. Erythema covered with yellow thick crust on knees |
| Shikino et al. [49] |
84 | M | III | Not specified | Poorly differentiated laryngeal SCC | T-4a, N-2c, M-0 | No | Radiation therapy | All fingernails | Yellow discoloration and proximal detachment | 2 months prior | Symmetric hyperkeratotic plaques of distal hands and feet. Violaceous desquamation on ears and nose |
| Adelman et al. [50] |
56 | F | II | Not specified | Poorly differentiated L oropharyngeal SCC | T-2, N-2c, M-0 | No | Chemoradiation with cisplatin | All finger and toenails | Ridging of nail beds and lifting of nails | 2 months post | Scaling over all fingers and toes. Dry gangrene on distal right third digit |
| Dabas et al. [51] | 50 | M | V | Not specified | Poorly differentiated SCC of base of the tongue | T-2, N-2c, M-1 | Centrilobular nodules in both lungs, consolidation in R upper and lower lobes, enlarged mediastinal lymph nodes |
None, patient died | All finger and toenails | Subungual hyperkeratosis, yellowish discoloration and thickening | 5 weeks prior | Symmetrical lichenoid scaly plaques on ears, and dorsum of hands |
| Mititelu et al. [52] | 72 | F | III | Not specified | NSCLC | Not specified | Not specified | Resection of the R upper lung lobe. Declined adjuvant chemotherapy | All finger and toenails | Thickened with longitudinal ridging and yellow discoloration | 4 months prior | Hyperkeratotic and fissured erythematous plaques on bilateral palmoplantar surfaces and lateral digits. Mild scaling on knees |
NSCLS, non-small-cell lung carcinoma; SCC, squamous cell carcinoma.
Primary malignancies were most often localized to the head and neck region (42%) and were most commonly squamous cell carcinomas (SCCs) of the esophagus. SCCs of the larynx, tongue, and oropharynx were also common forms of malignancies within the head and neck region. The lung was the second most common site of malignancy (21%), with mostly SCCs (6 patients). Gastrointestinal carcinomas represented 12% of the cases, most commonly adenocarcinomas. Genitourinary, cutaneous, breast, and thymic carcinomas were also reported as primary malignancies. Approximately 8% of the cases involved carcinomas were of indeterminate origin (Table 2). Metastases were present in 22 cases (46%), not present in 12 cases (25%), and not specified in 14 (29%) cases.
Table 2.
Summary of primary cancer locations and types of in patients with Bazex syndrome
| Primary cancer: location and type | Cases | Percentage |
|---|---|---|
| Carcinoma of head and neck region | 21 | 44 |
| SCC of the esophagus | 8 | 38 |
| SCC of the larynx and vocal cords | 4 | 19 |
| SCC of the tongue | 3 | 14 |
| SCC of pyriform sinus | 3 | 14 |
| Oropharyngeal carcinoma | 2 | 10 |
| Adenocarcinoma of the esophagus | 1 | 5 |
| Carcinoma of the lung | 10 | 21 |
| SCC | 6 | 60 |
| Epidermoid carcinoma | 1 | 10 |
| Adenocarcinoma | 1 | 10 |
| Small-cell lung carcinoma | 1 | 10 |
| NSCLC | 1 | 10 |
| Gastrointestinal carcinoma | 6 | 12 |
| Adenocarcinoma of Colon | 2 | 32 |
| Gastric adenocarcinoma | 1 | 17 |
| Adenocarcinoma of colon | 1 | 17 |
| Adenocarcinoma of the choledoch | 1 | 17 |
| Adenocarcinoma of rectosigmoid junction | 1 | 17 |
| Hepatocellular carcinoma | ||
| Genitourinary carcinoma | 2 | 4 |
| Cervical SCC | 1 | 50 |
| Transitional-cell carcinoma of bladder | 1 | 50 |
| Cutaneous carcinoma | 2 | 4 |
| SCC | 2 | 100 |
| Carcinoma of breast | 1 | 2 |
| Lobular carcinoma | 1 | 100 |
| Sarcoma | 1 | 2 |
| Liposarcoma of retroperitoneum | 1 | 100 |
| Thymic carcinoma | 1 | 2 |
| Indeterminate origin | 4 | 8 |
| SCC | 2 | 50 |
| Anaplastic carcinoma | 2 | 50 |
SCC, squamous cell carcinoma; NSCLS, non-small-cell lung carcinoma.
Nail changes in acrokeratosis paraneoplastica patients were nonspecific and varied (Table 3). The most common nail findings were nail plate thickening (35%), subungual hyperkeratosis (31%), yellow/brown nail plate discoloration (27%), onycholysis (27%), longitudinal ridging (25%), and loss or destruction of the nail plate (13%) (Fig. 1, 2). Paronychia was seen in 6% of the cases, often causing pain. Many patients had 2 or more nail findings concurrently; nail plate thickening and subungual hyperkeratosis were most common. Approximately, 79% of the patients had nail findings prior to cancer diagnosis, with onychodystrophies on average presenting in the preceding 10 months. In about 10% of the patients, nail changes occurred following malignancy diagnosis with an average of 14 months post-diagnosis. Nail findings presented concurrently with the diagnosis of cancer in about 6% of the cases, and the timing of nail findings were not specified in 5% of the cases. The majority of fingernails and toenails were involved in all cases except for one in which the onychodystrophy was limited to one fingernail.
Table 3.
Summary of nail findings in patients with Bazex syndrome
| Nail changes | Percentage |
|---|---|
| Thickening/onychauxis | 35 |
| Subungual hyperkeratosis | 31 |
| Yellow/brown discoloration | 27 |
| Onycholysis | 27 |
| Longitudinal ridging | 25 |
| Loss/destruction of nail plate | 13 |
| Fissuring | 8 |
| Onychomadesis | 6 |
| Paronychia | 6 |
| Horizontal ridging | 4 |
| Tenderness of nail | 4 |
| Crumbling/cracking | 4 |
| Loss of cuticles | 4 |
| Irregular pitting | 2 |
| Brittle | 2 |
| Atrophy | 2 |
| Candidal onychomycosis | 2 |
| Clubbing | 2 |
| Unspecified | 13 |
Fig. 1.
Acrokeratosis paraneoplastica. Nail plate yellowing, onycholysis, and subungual hyperkeratosis in a 51-year-old male with metastatic SCC of the esophagus. This figure has been reproduced with permission of Elsevier (Viteri et al. [29]). SCC, squamous cell carcinoma.
Fig. 2.
Acrokeratosis paraneoplastica. Nail plate thickening and yellow and brown discoloration of all fingernails and toenails in a 75-year-old male with hepatocellular carcinoma. This figure has been reproduced with permission of John Wiley and Sons (Goto et al. [39]).
Discussion
In our review of 48 cases of acrokeratosis paraneoplastica with nail findings, 36 patients (75%) were males, with a mean age of 62.5 years, and the majority of patients were either Caucasian or White (23%). The majority of patients were of Fitzpatrick skin type I–II (31%), followed by skin type III–IV (27%), and skin type V–VI (23%). Our findings are consistent with those of Bolognia et al. [1], who reviewed 93 cases of acrokeratosis paraneoplastica (with and without nails findings) and reported that 89/93 patients were males (96%) with a mean age of 60 ± 8.5 years. In a more recent review on Bazex syndrome (not nail specific) by Räßler et al. [6], 54/70 (77%) patients were males, with mean ages of 65 and 62 years for patients with nail findings and no nail findings, respectively.
In our study of Bazex patients with nail findings, malignancies were most commonly localized to the head and neck (44%), followed by the lung (21%), and gastrointestinal tract (12%). In addition, metastatic anaplastic tumors and SCCs of unknown primary origins accounted for 8% of the cases. Other types of carcinomas in our review included cervical SCC, transitional-cell carcinoma of the bladder, lobular carcinoma of the breast, liposarcoma, cutaneous SCCs, and thymic carcinoma. SCCs of the head and neck were also the most commonly reported underlying malignancies in Bazex syndrome, in patients with and without nail findings, in prior reviews. Bolognia et al. [1] reported that 57/93 patients (61%) had SCC of the esophagus, larynx, or pharynx. Other common sites included the lung and the gastrointestinal tract. Räßler et al. [6] reported that 11/77 patients (14%) had a primary malignancy of the lung, 8/77 patients (11%) had adenocarcinoma of the gastrointestinal tract, and 6/77 cases (8%) had metastatic anaplastic tumors of unknown origins with lymph node metastases of occult carcinomas. There was a case of T-cell lymphoma [7] and a neuroendocrine tumor [8] in patients with acrokeratosis paraneoplastica; however, those patients did not present with any nail changes.
We found that nail changes presented at an average of 10 months prior to malignancy diagnosis for 79% of the Bazex patients. In 2 cases, nail changes presented simultaneously with carcinoma recurrence [9, 10]. Our nail data are consistent with those of Bolognia et al. [1], who reported that in 63% of the Bazex patients, cutaneous manifestations preceded the diagnosis of malignancy, at an average time of 11 months. Nail findings typically appeared concurrently with the initial cutaneous manifestations; Bazex and Griffiths [4] described the cutaneous presentation of acrokeratosis paraneoplastica occurring in 3 stages. In the first stage, papulosquamous plaques present on the distal digits, nose, and ears, along with nail dystrophy [1, 4]. In the second stage, the papulosquamous plaques extend to the cheeks, palms, and soles. In the third stage, typically when metastases occur, the plaques spread to the elbows, knees, and dorsae of the hands and feet [1].
In our review, the most common nail changes were nail plate thickening, subungual hyperkeratosis, yellow or brown nail plate discoloration, onycholysis, longitudinal ridging, and loss or destruction of nail plate. Presentation with 2 or more nail changes simultaneously was frequent. Paronychia, while less common than some of the other nail findings, is an important source of morbidity in these patients. Bolognia et al. [1] reported on similar nail findings associated with acrokeratosis paraneoplastica as in our study; less common nail changes were macerated nails, atrophy, slow growth, and nail plate loss.
Our review is subject to several limitations. Due to the rarity of Bazex Syndrome, there were only 48 cases with associated nail findings published. In some case reports, photograph quality was insufficient to characterize specific nail changes, and/or detailed descriptions of nail findings and digits affected were lacking. Patient demographics were not reported in some cases, and Fitzpatrick skin types were not discernible for others.
A broad variety of nail findings are associated with acrokeratosis paraneoplastica, with many patients presenting with more than one type of onychodystrophy. The changes often affected most or all nails and presented concurrently with cutaneous findings. No nail changes were diagnostic or specific. The presence of subungual hyperkeratosis, onycholysis, nail plate thickening, longitudinal ridging, onychomadesis, yellow or brown nail plate discoloration, paronychia, nail plate loss and less common changes such as horizontal ridging, onychomycosis, atrophy, clubbing, pitting, and fissuring involving most or all nails should raise suspicion for acrokeratosis paraneoplastica, especially accompanied by the characteristic cutaneous lesions. When a patient presents with papulosquamous plaques on the skin accompanied by nail dystrophy, psoriasis is an important diagnostic consideration. Nail clippings and/or cultures may be performed to rule out other nail conditions in the differential diagnosis, such as onychomycosis or nail psoriasis. In the absence of hyphae, infiltration of neutrophils, and subungual hyperkeratosis in nail plate clippings, dermatologists should be prompted to perform a thorough review of systems, physical examination with palpation of lymph nodes, and referral to primary care for age appropriate malignancy screening and further testing if dictated by physical findings. Since nail changes typically present almost a year prior to diagnosis of malignancy, careful examination of the nails, hands, and digits and appropriate malignancy workup may be lifesaving. In addition, nail alterations in patients with acrokeratosis paraneoplastica should be monitored closely, since onychodystrophies may present during disease recurrence.
Conflict of Interest Statement
The authors have no conflict of interest to declare. This manuscript was not funded. This work has not been previously presented and is not under consideration at any other journal. No reprints requested.
Funding Sources
The authors did not receive any funding.
Author Contributions
Ms. Bipasha Roy has contributed to the conception and design of the work, acquisition, analysis, and interpretation of the data. Bipasha Roy has contributed to drafting the work and revising it critically, has been involved in the final approval of the version to be published, and agrees to be accountable for all aspects of the work in ensuring that questions related to accuracy or integrity of any part of the work are appropriately investigated and resolved.
Dr. Shari Lipner has contributed to the conception and design of the work, acquisition, analysis, and interpretation of the data. Dr. Shari Lipner has contributed to drafting the work and revising it critically, has been involved in the final approval of the version to be published, and agrees to be accountable for all aspects of the work in ensuring that questions related to accuracy or integrity of any part of the work are appropriately investigated and resolved.
References
- 1.Bolognia JL, Brewer YP, Cooper DL. Bazex syndrome (acrokeratosis paraneoplastica). An analytic review. Medicine. 1991;70((4)):269–80. doi: 10.1097/00005792-199107000-00004. [DOI] [PubMed] [Google Scholar]
- 2.Sharma V, Sharma NL, Ranjan N, Tegta GR, Sarin S. Acrokeratosis paraneoplastica (Bazex syndrome): case report and review of literature. Dermatol Online J. 2006 Jan 27;12((1)):11. [PubMed] [Google Scholar]
- 3.Khachemoune A, Yalamanchili R, Rodriguez C. Bazex syndrome (paraneoplastic acrokeratosis) Cutis. 2004;74((5)):289–92. [PubMed] [Google Scholar]
- 4.Bazex A, Griffiths A. Acrokeratosis paraneoplastica: a new cutaneous marker of malignancy. Br J Dermatol. 1980;103((3)):301–6. doi: 10.1111/j.1365-2133.1980.tb07248.x. [DOI] [PubMed] [Google Scholar]
- 5.Oakley A. Fitzpatrick skin phototype. DermNetzNZ. 2012 [Google Scholar]
- 6.Räßler F, Goetze S, Elsner P. Acrokeratosis paraneoplastica (Bazex syndrome): a systematic review on risk factors, diagnosis, prognosis and management. J Eur Acad Dermatol Venereol. 2017;31:1119–36. doi: 10.1111/jdv.14199. [DOI] [PubMed] [Google Scholar]
- 7.Lin YC, Chu CY, Chiu HC. Acrokeratosis paraneoplastica (Bazex's syndrome): unusual association with a peripheral T‐cell lymphoma. Acta Derm Venereol. 2001;81:440–1. doi: 10.1080/000155501317208471. [DOI] [PubMed] [Google Scholar]
- 8.Halpern SM, O'Donnell LJ, Makunura CN. Acrokeratosis paraneoplastica of Bazex in association with a metastatic neuroendocrine tumour. J R Soc Med. 1995;88((6)):353p–4p. [PMC free article] [PubMed] [Google Scholar]
- 9.O'Brien TJ. Bazex syndrome (acrokeratosis paraneoplastica) Australas J Dermatol. 1995;36((2)):91–3. doi: 10.1111/j.1440-0960.1995.tb00940.x. [DOI] [PubMed] [Google Scholar]
- 10.Taher M, Grewal P, Gunn B, Tonkin K, Lauzon G. Acrokeratosis paraneoplastica (Bazex syndrome) presenting in a patient with metastatic breast carcinoma: possible etiologic role of zinc. J Cutan Med Surg. 2007;11((2)):78–83. doi: 10.2310/7750.2007.00015. [DOI] [PubMed] [Google Scholar]
- 11.Jacobsen FK, Abildtrup N, Laursen SO, Brandrup F, Jensen NK. Acrokeratosis paraneoplastica (Bazex' syndrome) Arch Dermatol. 1984;120((4)):502–4. [PubMed] [Google Scholar]
- 12.Richard M, Giroux JM. Acrokeratosis paraneoplastica (Bazex' syndrome) J Am Acad Dermatol. 1987;16((1 Pt 2)):178–83. doi: 10.1016/s0190-9622(87)80057-9. [DOI] [PubMed] [Google Scholar]
- 13.Douglas WS, Bilsland DJ, Howatson R. Acrokeratosis paraneoplastica of Bazex: a case in the UK. Clin Exp Dermatol. 1991;16((4)):297–9. doi: 10.1111/j.1365-2230.1991.tb00381.x. [DOI] [PubMed] [Google Scholar]
- 14.Handfield-Jones SE, Matthews CN, Ellis JP, Das KB, McGibbon DH. Acrokeratosis paraneoplastica of Bazex. J R Soc Med. 1992;85((9)):548–50. doi: 10.1177/014107689208500913. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Mounsey R, Brown DH. Bazex syndrome. Otolaryngol Head Neck Surg. 1992;107((3)):475–7. doi: 10.1177/019459989210700326. [DOI] [PubMed] [Google Scholar]
- 16.Poskitt BL, Duffill MB. Acrokeratosis paraneoplastica of Bazex presenting with carpal tunnel syndrome. Br J Dermatol. 1992;127((5)):544–5. doi: 10.1111/j.1365-2133.1992.tb14860.x. [DOI] [PubMed] [Google Scholar]
- 17.Arregui MA, Ratón JA, Landa N, Izu R, Eizaquirre X, Díaz-Pérez JL. Bazex's syndrome (acrokeratosis paraneoplastica)-first case report of association with a bladder carcinoma. Clin Exp Dermatol. 1993;18((5)):445–8. doi: 10.1111/j.1365-2230.1993.tb02247.x. [DOI] [PubMed] [Google Scholar]
- 18.Hara M, Hunayama M, Aiba S, Suetake T, Watanabe M, Tanaka M, et al. Acrokeratosis paraneoplastica (Bazex syndrome) associated with primary cutaneous squamous cell carcinoma of the lower leg, vitiligo and alopecia areata. Br J Dermatol. 1995;133((1)):121–4. doi: 10.1111/j.1365-2133.1995.tb02504.x. [DOI] [PubMed] [Google Scholar]
- 19.Laccourreye O, Laccourreye L, Jouffre V, Brasnu D. Bazex's acrokeratosis paraneoplastica. Ann Otol Rhinol Laryngol. 1996;105((6)):487–9. doi: 10.1177/000348949610500614. [DOI] [PubMed] [Google Scholar]
- 20.Wareing MJ, Vaughan-Jones SA, McGibbon DH. Acrokeratosis paraneoplastica: Bazex syndrome. J Laryngol Otol. 1996;110((9)):899–900. doi: 10.1017/s0022215100135297. [DOI] [PubMed] [Google Scholar]
- 21.Sarkar B, Knecht R, Sarkar C, Weidauer H. Bazex syndrome (acrokeratosis paraneoplastica) Eur Arch Otorhinolaryngol. 1998;255((4)):205–10. doi: 10.1007/s004050050044. [DOI] [PubMed] [Google Scholar]
- 22.Mutasim DF, Meiri G. Bazex syndrome mimicking a primary autoimmune bullous disorder. J Am Acad Dermatol. 1999;40((5 Pt 2)):822–5. doi: 10.1053/jd.1999.v40.a95652. [DOI] [PubMed] [Google Scholar]
- 23.Hsu YS, Lien GS, Lai HH, Cheng YS, Hu CH, Hsieh MC, et al. Acrokeratosis paraneoplastica (Bazex syndrome) with adenocarcinoma of the colon: report of a case and review of the literature. J Gastroenterol. 2000;35((6)):460–4. doi: 10.1007/s005350070092. [DOI] [PubMed] [Google Scholar]
- 24.Buxtorf K, Hübscher E, Panizzon R. Bazex syndrome. Dermatology. 2001;202((4)):350–2. doi: 10.1159/000051680. [DOI] [PubMed] [Google Scholar]
- 25.Gill D, Fergin P, Kelly J. Bullous lesions in Bazex syndrome and successful treatment with oral psoralen phototherapy. Australas J Dermatol. 2001;42((4)):278–80. doi: 10.1046/j.1440-0960.2001.00535.x. [DOI] [PubMed] [Google Scholar]
- 26.Chave TA, Bamford WM, Harman KE. Acrokeratosis paraneoplastica associated with recurrent metastatic thymic carcinoma. Clin Exp Dermatol. 2004;29((4)):430–2. doi: 10.1111/j.1365-2230.2004.01539.x. [DOI] [PubMed] [Google Scholar]
- 27.Rao R, Shenoi SD. Acrokeratosis paraneoplastica (Bazex syndrome): an atypical presentation. Dermatol Online J. 2004;10((1)):21. [PubMed] [Google Scholar]
- 28.Valdivielso M, Longo I, Suárez R, Huerta M, Lázaro P. Acrokeratosis paraneoplastica: Bazex syndrome. J Eur Acad Dermatol Venereol. 2005;19((3)):340–4. doi: 10.1111/j.1468-3083.2005.01083.x. [DOI] [PubMed] [Google Scholar]
- 29.Viteri A, Muñoz A, Barcelò R. Acrokeratosis paraneoplastica (Bazex syndrome) preceeding the diagnosis of metastatic squamous cell carcinoma of the esophagus. J Am Acad Dermatol. 2005;52((4)):711–2. doi: 10.1016/j.jaad.2004.12.017. [DOI] [PubMed] [Google Scholar]
- 30.Karabulut AA, Sahin S, Sahin M, Ekşioğlu M, Ustün H. Paraneoplastic acrokeratosis of Bazex (Bazex's syndrome): report of a female case associated with cholangiocarcinoma and review of the published work. J Dermatol. 2006;33((12)):850–4. doi: 10.1111/j.1346-8138.2006.00194.x. [DOI] [PubMed] [Google Scholar]
- 31.Sator PG, Breier F, Gschnait F. Acrokeratosis paraneoplastica (Bazex's syndrome): association with liposarcoma. J Am Acad Dermatol. 2006;55((6)):1103–5. doi: 10.1016/j.jaad.2006.05.064. [DOI] [PubMed] [Google Scholar]
- 32.Strobel ES, Bouveret C, Kohl PK. Acrokeratosis paraneoplastica of Bazex as an indicator for underlying squamous cell carcinoma of the lung. J Cancer Res Clin Oncol. 2006;132((6)):376–8. doi: 10.1007/s00432-006-0078-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Poligone B, Christensen SR, Lazova R, Heald PW. Bazex syndrome (acrokeratosis paraneoplastica) Lancet. 2007;369((9560)):530. doi: 10.1016/S0140-6736(07)60240-2. [DOI] [PubMed] [Google Scholar]
- 34.Baek JO, Lee HY, Lee JR, Roh JY. Acrokeratosis Paraneoplastica with adenocarcinoma of the colon treated with topical tretinoin. Ann Dermatol. 2008;20((4)):216–20. doi: 10.5021/ad.2008.20.4.216. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Medenica L, Gajić-Veljić M, Skiljević D, Pesko P. Acrokeratosis paraneoplastica Bazex syndrome associated with esophageal squamocellular carcinoma. Vojnosanit Pregl. 2008;65((6)):485–7. doi: 10.2298/vsp0806485m. [DOI] [PubMed] [Google Scholar]
- 36.Crucitti A, Feliciani C, Grossi U, La Greca A, Porziella V, Giustacchini P, et al. Paraneoplastic acrokeratosis (Bazex syndrome) in lung cancer. J Clin Oncol. 2009;27((36)):e266–8. doi: 10.1200/JCO.2009.22.6852. [DOI] [PubMed] [Google Scholar]
- 37.Medenica L, Gajić-Veljić M, Skiljević D, Pesko P. Acrokeratosis paraneoplastica Bazex syndrome associated with esophageal squamocellular carcinoma. Vojnosanit Pregl. 2008;65((6)):485–7. doi: 10.2298/vsp0806485m. [DOI] [PubMed] [Google Scholar]
- 38.Santos-Silva AR, Correa MB, Vargas PA, Almeida OP, Lopes MA. Bazex syndrome (acrokeratosis paraneoplastica) diagnosed in a patient with oral persistent ulcerations. Head Neck Pathol. 2010;4((4)):312–7. doi: 10.1007/s12105-010-0203-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Goto H, Hara H, Takayanagi T, Terui T. Coexistence of papuloerythroderma of Ofuji and acrokeratosis paraneoplastica (Bazex syndrome) preceding the diagnosis of primary hepatocellular carcinoma. Int J Dermatol. 2011;50((11)):1393–6. doi: 10.1111/j.1365-4632.2010.04852.x. [DOI] [PubMed] [Google Scholar]
- 40.Zarzour JG, Singh S, Andea A, Cafardi JA. Acrokeratosis paraneoplastica (Bazex syndrome): report of a case associated with small cell lung carcinoma and review of the literature. J Radiol Case Rep. 2011;5((7)):1–6. doi: 10.3941/jrcr.v5i7.663. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Rodrigues IA, Jr, Gresta LT, Cruz RC, Carvalho GG, Moreira MH. Bazex syndrome. An Bras Dermatol. 2013;88((6 Suppl 1)):209–11. doi: 10.1590/abd1806-4841.20132488. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Fleming JD, Stefanato CM, Attard NR. Bazex syndrome (acrokeratosis paraneoplastica) Clin Exp Dermatol. 2014;39((8)):955–6. doi: 10.1111/ced.12353. [DOI] [PubMed] [Google Scholar]
- 43.Graves MS, Hardin ME, Davis LS. A case of bazex syndrome with genital involvement. JAMA Dermatol. 2014;150((12)):1368–70. doi: 10.1001/jamadermatol.2014.2110. [DOI] [PubMed] [Google Scholar]
- 44.Robert M, Gilabert M, Rahal S, Ries P, Raoul JL. Bazex syndrome revealing a gastric cancer. Case Rep Oncol. 2014;7((1)):285–7. doi: 10.1159/000362787. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Amano M, Hanafusa T, Chikazawa S, Ueno M, Namiki T, Igawa K, et al. Bazex syndrome in lung squamous cell carcinoma: high expression of epidermal growth factor receptor in lesional keratinocytes with Th2 immune shift. Case Rep Dermatol. 2016;8((3)):358–62. doi: 10.1159/000452827. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Squires B, Daveluy SD, Joiner MC, Hurst N, Bishop M, Miller SR. Acrokeratosis paraneoplastica associated with cervical squamous cell carcinoma. Case Rep Dermatol Med. 2016;2016:7137691. doi: 10.1155/2016/7137691. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Vatandoust S, McKay BP, McLeay W, Miliauskas J, Gordon L, Wesley JA, et al. Acrokeratosis paraneoplastica (Bazex syndrome) associated with metastatic cutaneous squamous cell carcinoma. Intern Med J. 2016;46((1)):119–20. doi: 10.1111/imj.12955. [DOI] [PubMed] [Google Scholar]
- 48.Zhao J, Zhang X, Chen Z, Wu JH. Case report: Bazex syndrome associated with pulmonary adenocarcinoma. Medicine. 2016;95((2)):e2415. doi: 10.1097/MD.0000000000002415. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Shikino K, Ikusaka M. Bazex syndrome. CMAJ. 2017;189((17)):E639. doi: 10.1503/cmaj.160912. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Adelman ML, Ho QA, Agrawal A. Bazex syndrome in a patient with head and neck malignancy. JAAPA. 2018;31((6)):30–3. doi: 10.1097/01.JAA.0000532114.67884.94. [DOI] [PubMed] [Google Scholar]
- 51.Dabas G, De D, Handa S, Chatterjee D, Radotra BD. Acrokeratosis paraneoplastica (Bazex syndrome) QJM. 2018;111((1)):63–4. doi: 10.1093/qjmed/hcx187. [DOI] [PubMed] [Google Scholar]
- 52.Mititelu R, Powell M. A case report of resolution of acrokeratosis paraneoplastica (Bazex syndrome) post resection of non-small-cell lung carcinoma. SAGE Open Med Case Rep. 2019;7:2050313X19881595. doi: 10.1177/2050313X19881595. [DOI] [PMC free article] [PubMed] [Google Scholar]


